Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001567619-22-008008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | PCSA | THOMPSON VIRGIL | Dir | A - Grant | — | +4,393 | 16.7K | +36% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | A | A | 4,393 | — | 16,693 | D | — | — | (F1) Vesting of time-based restricted shares. |